Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuaitong Liu

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Medical Virology|December 12, 2022
Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcomaLilly Gu, Erica Lin, Shuaitong Liu, et al.
Cell Reports|November 21, 2019
Nuclear Exosome Targeting Complex Core Factor Zcchc8 Regulates the Degradation of LINE1 RNA in Early Embryos and Embryonic Stem CellsYou Wu, Wenqiang Liu, Jiayu Chen, et al.
The Journal of Experimental Medicine|May 5, 2023
OX40L-expressing recombinant modified vaccinia virus Ankara induces potent antitumor immunity via reprogramming TregsNing Yang, Yi Wang, Shuaitong Liu, et al.
Nature Communications|September 9, 2022
In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy responseAditi Sahu, Kivanc Kose, Lukas Kraehenbuehl, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Medical Virology|December 12, 2022
Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcomaLilly Gu, Erica Lin, Shuaitong Liu, et al.
Cell Reports|November 21, 2019
Nuclear Exosome Targeting Complex Core Factor Zcchc8 Regulates the Degradation of LINE1 RNA in Early Embryos and Embryonic Stem CellsYou Wu, Wenqiang Liu, Jiayu Chen, et al.
The Journal of Experimental Medicine|May 5, 2023
OX40L-expressing recombinant modified vaccinia virus Ankara induces potent antitumor immunity via reprogramming TregsNing Yang, Yi Wang, Shuaitong Liu, et al.
Nature Communications|September 9, 2022
In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy responseAditi Sahu, Kivanc Kose, Lukas Kraehenbuehl, et al.
Pageof 2